Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A Multi-Center Phase III Clinical Trial to Assess the Influence to Bleeding and Anticoagulant Effect of Nafamostat Mesilate (Futhan) in Hemodialysis Patients with High Bleeding-Risk
- Issue Date
- 2004
- Keywords
- Hemodialysis; Anticoagulation; Nafamostat mesilate (Futhan); Bleeding- risk
- Citation
- Kidney Research and Clinical Practice, v.23, no.6, pp 920 - 926
- Pages
- 7
- Indexed
- KCICANDI
- Journal Title
- Kidney Research and Clinical Practice
- Volume
- 23
- Number
- 6
- Start Page
- 920
- End Page
- 926
- ISSN
- 2211-9132
2211-9140
- Files in This Item
- There are no files associated with this item.
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Kim, Hyoung Kyu
- Anam Hospital (Department of Nephrology and Hypertension, Anam Hospital)